POPULARITY
Earlier this month, the Government of Saskatchewan announced an expansion of pharmacy services in the province. Michael Fougere, CEO for the Pharmacy Association of Saskatchewan, joins Evan to discuss what this change will mean for pharmacists and patients.
HEALTHCARE PROFESSIONALS IMMIGRATION PILOT (LETTER OF INTEREST), released by Nova Scotia on 28 August 2024 | Good day ladies and gentlemen, this is IRC news, I am Joy Stephen, a certified Canadian Immigration practitioner, and I bring to you this Provincial News Bulletin from the province of Nova Scotia. This recording originates from the Polinsys studios in Cambridge, Ontario. | This is not a Labour Market Priorities draw. If you received a Letter of Interest from Nova Scotia in your Express Entry profile on August 28, 2024, you are invited to participate in the pharmacist and pharmacy technician draw of the Healthcare Professionals Immigration Pilot. If you wish to proceed, follow the links below: Pharmacists (NOC 31120): https://jobs.lever.co/pansns/9456ff9e-da7b-4ce4-8bc6-3a712634bc64/apply Pharmacy Technicians (NOC 32124): https://jobs.lever.co/pansns/c01128ae-b93d-43e7-ae86-1e8c0c46ef25/apply These links will take you to complete a survey to express your interest in becoming a pharmacist or pharmacy technician in Nova Scotia. By doing so, you are applying for employment through a process facilitated by the Nova Scotia Office of Healthcare Professionals Recruitment, the Pharmacy Association of Nova Scotia, and the Nova Scotia College of Pharmacists. The information you provide will be shared with an employer in the sector. If you are unable to access the survey, contact IEHP-IMM@novascotia.ca If you receive a conditional job offer from a Nova Scotia healthcare employer, you may apply to the Nova Scotia Nominee Program or the Atlantic Immigration Program. Only pharmacists and pharmacy technicians who receive a Letter of Interest from Nova Scotia in their Express Entry profile on August 28, 2024, are eligible to participate in the draw. Your profile will continue to be included in the federal Express Entry pool. The Healthcare Professionals Immigration Pilot is a pathway for permanent residency under a non-Express Entry stream of the Nova Scotia Nominee Program or the Atlantic Immigration Program. You will NOT receive 600 points in your Express Entry profile. If you are a healthcare professional who is ineligible for this draw, we encourage you to review other programs or streams. | You can always access past news from the Province of Nova Scotia by visiting this link: https://myar.me/tag/ns/. Furthermore, if you are interested in gaining comprehensive insights into the Provincial Express Entry Federal pool Canadian Permanent Residence Program or other Canadian Federal or Provincial Immigration programs, or if you require guidance after your selection, we cordially invite you to connect with us through https://myar.me/c. We highly recommend participating in our complimentary Zoom resource meetings, which take place every Thursday. We kindly request you to carefully review the available resources. Should any questions arise, our team of Canadian Authorized Representatives is readily available to address your concerns during the weekly AR's Q&A session held on Fridays. You can find the details for both of these meetings at
More pharmacies are now requiring 24 to 48 hours notice to fill prescriptions. It's a shift pharmacies are making to help them respond to an increase in demand and a growing complexity of care. Allison Bodnar is CEO of the Pharmacy Association of Nova Scotia.
Morgan is in the field at the Georgia Pharmacy Association Conference talking with Tonya Treadwell of the Medicine Cabinet in La Grange Georgia. They're taking a trip down memory lane about when Morgan first got out of pharmacy school and what the future will bring.
If you're a Manulife insurance client, you've likely checked your list of prescriptions by now. The company announced a deal with Loblaw this month, such that certain "specialty" medications will only be covered at a Loblaw-owned pharmacy. Curtis Chafe is a pharmacist, and sits on the board for the Pharmacy Association of Nova Scotia. He tells us what this change means for patients in the province.
Some pharmacists are part of a pilot project that expands their role to include clinical work. It's an effort to help lighten the load on our strained healthcare system. Meanwhile, many pharmacists across the country are reporting burnout and having to reduce hours due to staffing shortages. Allison Bodnar from the Pharmacy Association of Nova Scotia talks about how pharmacists are managing their new clinical responsibilities.
It's been more than a decade since the Nova Scotia government has made it possible for pharmacists in the province to be more active in delivering primary health care. But there are still people who don't know about all of the services that are available to them. And there are also people who can't afford to access those services because they aren't covered by the province. Opposition politicians are calling for that to change. And Allison Bodnar, the CEO of the Pharmacy Association of Nova Scotia, is optimistic but yet realistic about the pace of that change.
Mother Hubbard's taken over the pharmacies in the province: the cupboards, the shelves and the stockrooms are bare! But your local drug expert in the white coat might still be able to help if you or your child is sick. We check in with the president of the Pharmacy Association of Newfoundland and Labrador.... as well as with one of those sick children and her dad. (Anthony Germain with Dr. Janice Audeau; Student Kate Winnett and her dad Alan)
Diane Harpell who's a pharmacist in Dartmouth and also chairs the Pharmacy Association of NS explains why her organization wants people to continue wearing a mask on pharmacies, even though Covid mandates have largely been dropped in NS. We hear your feedback on masks. And on the phone-in: Wildlife biologist Bob Bancroft
Now that we're two years into the global pandemic, we've learned a lot about the frailties and limits in many of our health care systems. And when the vaccines started becoming available, we saw a pivot for pharmacies as they became front lines for public health care. March is Pharmacy Appreciation Month. And Allison Bodnar is the CEO of the Pharmacy Association of Nova Scotia (PANS). They are taking some time this year to recognize the innovations they've brought to the health care system in Nova Scotia. And they're looking ahead to other ways they can become more of a front line partner moving forward.
Diane Harpell, who's a pharmacist in Dartmouth and chair of the Pharmacy Association of Nova Scotia, comments on the big demand for flu shots this season. She says her phone has been ringing off the hook. And on the phone-in: Coastal erosion. Our guest is Rosmarie Lohnes
Justin Bates, CEO, Ontario Pharmacists Association talks about Pharmacy Association warning that AstraZeneca doses may expire before it gets into arms. See omnystudio.com/listener for privacy information.
Ann Rohmer speaks about the Ontario Medical Association's advice to the Provincial Government to avoid a third wave of COVID-19. Tina Cortese discusses how your local pharmacy will be involved in the vaccine roll-out and also talks to York Region's CEO Chairman Wayne Emmerson on how things are going after the first week of York Region being in the 'Red Zone'. With the RRSP deadline on March 1st, Jim Lang discusses making a contribution during these challenging times. Karen Johnson looks at how a local retailer (Lou Lou Boutique) has changed its business model during the pandemic. Ann Rohmer brings us a story about 36 golden retrievers that were abused in Cairo, but have arrived a Pearson Airport and found their forever homes here.
Nova Scotia pharmacies have been giving out flu vaccines, but unless something changes, that could be at an end. Diane Harpell is vice-chair with the Pharmacy Association of Nova Scotia.
Flu season has started but the high dose flu shot is proving hard to find. Diane Harpell Vice-Chair of the Pharmacy Association of Nova Scotia tells us why.
Ep 288 - Your Pharmacist and Covid19 Guest: Annette Robinson - Derek Desrosiers Are pharmacists an underutilized health care resource in the fight against the Coronavirus? “Pharmacists are the most accessible health care professionals in BC,” says Annette Robinson, the Vice-President of the Pharmacy Association. “One reason pharmacists may be overlooked is due to a perception that they are merely prescription fillers.” Past BCPhA President Derek Desrosiers says, “Pharmacists are the drug specialists for sure, but the scope of practice for them has expanded over the years. Past health care crises forced the healthcare system to empower and enlist pharmacists to not only provide flu shots, but fill emergency prescriptions and manage adaptations.” What it adds up to is an additional health care provider who is available seven days a week, from early in the morning to late at night. We invited Annette Robinson and Derek Desrosiers to join us for a Conversation That Matter about a health care resource you may have overlooked. Conversations That Matter is a partner program for the Morris J Wosk Center for Dialogue at Simon Fraser University. The production of this program is made possible thanks to the support of the following and viewers like you. Please become a Patreon subscriber and support the production of this program, with a $1 pledge https://goo.gl/ypXyDs
Quarantine, Covidiots, Pandemic Parodies, and Myla Bulych of the Pharmacy Association of Saskatchewan talks pharmacies in this tough time.
Thank you for the opportunity to take the month of January off from social media! It was restorative. But...no rest for the wicked now! Here's what I did during my time away: 1. Talked about meetings with my friend Chad Priest. BTW, here's my podcast interview with him from season 1: https://podcasts.apple.com/us/podcast/nurse-attorney-emergency-disaster-expert-chad-priest/id1355247028?i=1000460798891 2. Read more books and wrote some blogs! Pecking order of senses and memory: https://medium.com/@ErinLAlbert/the-pecking-order-of-the-senses-for-learning-memory-8f78c8b60433 Ladies, we can be awesome, just not TOO awesome... https://medium.com/@ErinLAlbert/ladies-we-can-be-awesome-but-not-too-awesome-4e10e12dae23 What are you going to suck at in 2020? https://medium.com/@ErinLAlbert/what-are-you-going-to-suck-at-in-2020-e3767c75e275 3. Cleaned up the 2020 lists for... Pharmacy Association & Meeting/Conference List: https://payhip.com/b/TYHz Pharmacist and Healthcare Certifications, Certificates and Professional Designations List: https://payhip.com/b/XOVg We've got a bigger and badder than ever season 2 planned. Or not. But one thing is for sure: It's just. For. Y-O-U!
Making an impact in a broad way: That is the driving force for Michael Jackson's journey to becoming the Executive Vice President and the CEO of the Florida Pharmacy Association. Networking and building his personal brand played a key role in his life's work. Michael shares his wonderful life in advocacy and advice for others wanting to stay abreast of legislation affecting the pharmacy realm. Connect with Michael Jackson: Email: mjackson@pharmview.com FPA website: https://www.pharmview.com/ Connect with Heather Hardin: Facebook: https://www.facebook.com/pharmie LinkedIn: https://www.linkedin.com/in/heather-hardin-pharmd-bcacp-8022b829/ Instagram: pharmie_gal website: HaloHealth.net YouTube: Pharmacists Out of the Box Connect with Bryn Tenney: Email: BrynTenney@gmail.com Instagram: bryntenney YouTube: Pharmacists Out of the Box
An interview with Dr. Paul Celano from the greater Baltimore Medical Center, lead author on "Safe Handling of Hazardous Drugs: ASCO Standards." TRANSCRIPT The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Hello and welcome to the ASCO Guidelines podcast series. My name is Shannon McKernin. And today I'm interviewing Dr. Paul Celano from the greater Baltimore Medical Center, lead author on "Safe Handling of Hazardous Drugs: ASCO Standards." Thank you for being here today, Dr. Celano. Thank you for having me. I'm certainly glad to talk about these standards. They're very important to our employees and our patients. So first I want to make the distinction that this publication is not a guideline like we usually cover on this podcast. So can you tell us what standards are and how they differ from guidelines? Well, guidelines really are intended to guide practitioners around recommended care options. They give obviously a lot of latitude to clinical judgment and circumstances. Standards, on the other hand, are really meant primarily for the organization of care and are intended to have a higher level of obligation to help drive either practice or policy or even legislative efforts. So that's really the distinction. And what are the standard statements that are made by ASCO in this publication? The publication really is about safe handling of hazardous drugs. This all came about is because recently there have been a number of national guidelines or standards that have been offered by other organizations, but not specifically oncology or certainly ASCO or the ASCO organization. We felt a need to address the standards that have been put out on the basis of the evidence, so that best practices can be offered. Initially, we did collaborate with other societies, such as the Oncology Nursing Society and the Hematology Oncology Pharmacy Association. That was really the impetus behind making sure that we are, in a sense, congruent with standards that are already being published and discussed, but also to also place in our interpretation of these standards so that they're based on the best evidence that's available. And what qualifying statements are there to note about these standards? Well, I think the best way to look at these standards is there has been recently published or offered what's been called the UST 800 standards, which really incorporate other previous standards by the Pharmacy Association as well as OSHA, the Occupational Safety and Health Association, as well as NIOSH, the American Society of Hospital Pharmacists, Oncology Nursing, etc. So there's a lot of standards that have been offered. And in fact, the ASCO review of this really in a sense agrees with many of the standards that have already been published and offered-- types of exposures, the responsibilities of personnel handling the drugs, the personal protective equipment, how we communicate the hazardous drugs, the training of compounding personnel, how the drugs are dispensed and even transported. So there's lots of things that we really do agree with. I think it's also important to understand that the objectives of this is really to protect personnel and the environment to make sure the standards apply to all personnel who compound hazardous drugs and preparations, all places where hazardous drugs are prepared and stored, transported and administered. So that's really a key part of this. These are a comprehensive program really to prevent worker environmental exposure and to provide the most practical safety environment for all involved. So finally, why are these standards so important? And how will they affect practice? Well, they effect practice in many ways. I mean, the key thing is making sure that our employees, meaning the nurses, pharmacy, the technicians, really everyone involved that they're not unduly exposed to these hazardous drugs. And so that's really the key thing that we're all trying to achieve by this. Now, what really makes the sort of ASCO standards somewhat different or the things that we came into a contention with has to do with the differences that ASCO has come up with in contrast to some of the other standards. And these have to do with really four main areas within these standards. They have to do with medical surveillance, external ventilation, closed system transfer devices, and also proper assignment of our personnel while they may have either trying to conceive or pregnant or nursing. So those areas that in our review, the ASCO review, have come under some question. As an example, medical surveillance, there in some of the standards offered-- not ASCO's-- that there's a number of medical surveillance procedures that have been elucidated, that really we find, number one, have really not any proven value for our employees and generate a lot of confusion in terms of how this process is supposed to be done. Obviously, if one of our employees has some undue exposure, such as a spill of chemotherapy or even just have flat out a concern, then obviously those things will be clearly investigated. But to have general medical surveillance of all employees, really we did not feel was of great value. But also further, we really feel that this is an area where more research needs to be done to better elucidate really what should this process look like and what value are we providing to our employees. Another aspect of this is the use of what are called closed system transfer devices. Currently, there are a number of these devices available that there is interestingly no standard way that these devices have been evaluated. And so it's hard to recommend one device over another, because there is no standards for which they're really being compared. And there certainly have been no studies looking at really any form of health outcome that really help us to direct this to how best to use these devices. And so really, a lot of these objections are more around let's do things in an evidence-based way so we can better know how to best direct our practices. Another area of concern in terms of ASCO standards have been the implementation of external ventilation in either containment secondary engineering controls or other situations. And the challenges is that HEPA filters are probably appropriate for collecting solid or aerosolized particles, but don't capture vaporized drugs. But there's little data available on the ability of hazardous drugs to vaporize within the workplace environment and what those hazards really are. And so again, it's is a call for more research to have an optimal environment for preparing these drugs and without having to place undue burdens in terms of external ventilation. Another area is options for alternative duties for workers who are actively trying to conceive or are pregnant or breastfeeding. And these we recognize can be special burdens to small practices looking to implement alternative duty programs. There is a lot of controversy regarding the potential level of risk that really these workers really have. And basically our stance has been that we should have a policy that identifies alternative work options for workers who are trying to conceive, are pregnant or are breastfeeding, and that this information needs to be conveyed to these employees at the time of their hire so they understand what their risks are and what their options are within the workplace. Again, trying to make sure everyone is well informed and aware of what the work environment they're in and as their life circumstances change what they can do to change with this. I think the key is that we all feel that this is an area that we should have continued research on. And our standard, certainly ASCO's standards will continue to evolve as more and more research and evidence becomes available. Thank you so much for taking the time to explain these standards to us today, Dr. Celano. You're welcome. And thank you to all of our listeners for tuning into the ASCO Guidelines podcast series. If you've enjoyed what you've heard today, please rate and review the podcast and refer the show to a colleague
For Immediate Release Contact: Lisa Min Pharmacy Publishing Network (412) 585-4001 lmin@pharmacypublishingnetwork.com Iowa Pharmacy Association Joins the Pharmacy Podcast Network [Pittsburgh, PA April 22, 2019] The Pharmacy Podcast Network has officially partnered with the Iowa Pharmacy Association (IPA) to broadcast and support IPA through podcasting. IPA will host two new shows on the Pharmacy Podcast Network, ResilienceRx and Rx State of the States. “I am really excited about working with Kate Gainer and the IPA. They were already leveraging podcasting for their BOP Podcast, it's a clever board of pharmacy review and summary podcast” stated Todd Eury, founder of the Pharmacy Podcast Network, “quality produced and promoted podcasts are more important than ever with the popularity of the medium. The Pharmacy Podcast Network is celebrating our 10th year podcasting about the profession of pharmacy and the IPA joining the network is an anniversary present. We're excited.” Podcasting is growing. Apple confirmed there were over 550,000 podcasts at the annual WWDC 2018 conference in early June. And an article by Variety back in Feb 2018 said: Apple Podcasts features more than 500,000 active podcasts, including content in more than 100 languages. “The Pharmacy Podcast Network has been in the top 100 rankings in Apple podcasts for the category called business news for years. We need to expand the network, build out content pharmacists, pharmacy professionals, and pharmacy industry stakeholders want to hear” Eury continues, “The partnership with IPA will be a valuable source of interviews, panels, and content with connections to other state associations. These podcasts will be valuable to all pharmacy associations and industry professionals looking to catch up on some of the latest initiatives of our pharmacy organizations and leaders.” Kate Gainer, IPA's CEO and executive vice president, states, “IPA's podcasts are designed to educate and benefit pharmacists across the country. We are excited to partner with PPN, the leader in pharmacy podcasts. ResilienceRx is designed to help pharmacists grow amidst stress and Rx State of the States zooms in on major initiatives and legislative priorities for pharmacy practice advancement occurring across the country.” The IPA is the state society representing the profession of pharmacy in Iowa, united to empower the pharmacy profession to improve health outcomes. Since 1880, the Iowa Pharmacy Association is organized to preserve and advance the interests of the profession and to serve the professional needs of all pharmacists, student pharmacists, and pharmacy technicians. Pharmacy Publishing Network See omnystudio.com/listener for privacy information.
The Value Strategy GuyI help frustrated, overworked professionals worried about the state of their profession, select and implement the best value strategy possible so they can get paid what they are worth and build a secure future for themselves and their families. Special Guest Greg L. Alston, with Ben Coakley on the Income Outcomes Show. The profession of pharmacy has been an awesome career for me. It has allowed me the freedom to practice in a variety of environments and to provide for my family. But the profession I entered in 1977 is not the profession we are looking at today. And in my opinion, many of the commonly held beliefs about the profession are keeping people from being successful. My goal is to challenge your unsaid assumptions and internal biases. By challenging those biases, I believe you will discover a new world of opportunity for your career. There are three big misconceptions that I believe the profession has been singing the wrong song about. I don't think anybody has been doing this intentionally to harm the profession and yet I think the lack of progress the profession has made primarily emanates from some of these misguided assumptions. The Field of Dreams Strategy The first mantra that has been pounding through the profession for the last 40 years is what I call, the field of dreams strategy. We have felt that, “if we build it they will come.” We have believed that if we improved the clinical skills of our professional pharmacists that the public would willingly pay for these new services. However, this has failed to happen, and it has failed to happen because leadership misunderstands how value is created for a target market. A recent article in the American Journal of the Pharmacy Association pointed this out very clearly when their survey of patients who had been exposed to medication therapy management services came back with some unexpectedly negative results. Approximately 60% of the patients who were aware of the services and aware of what the pharmacist could do said they had no interest or not very much interest in receiving the services. Let me tell you what I think this means. It does not mean that those services are not valuable. It does not mean that people don't need those services. What it means is our profession has done a terrible job of marketing those services. We argue with ourselves. We write articles in our journals. We complained to our legislators. But we have never made a compelling case to our patients that what we do is critical for their health. There is no more clear proof of this than comparing what pharmacists have done for their profession to what dentists have done for their profession. If you ask any adult in America how often they need to go to their dentist to have a good thorough cleaning and inspection they will tell you every six months. If you ask anyone in America how often should a person taking multiple medications go to their pharmacist for a complete medication review, you will be met with blank stares. Again, we have done a terrible job of marketing our profession. See omnystudio.com/listener for privacy information.
The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Hello and welcome to the ASCO Guidelines podcast series. My name is Shannon McKernin. And today I'm interviewing Dr. Paul Celano from the greater Baltimore Medical Center, lead author on "Safe Handling of Hazardous Drugs: ASCO Standards." Thank you for being here today, Dr. Celano. Thank you for having me. I'm certainly glad to talk about these standards. They're very important to our employees and our patients. So first I want to make the distinction that this publication is not a guideline like we usually cover on this podcast. So can you tell us what standards are and how they differ from guidelines? Well, guidelines really are intended to guide practitioners around recommended care options. They give obviously a lot of latitude to clinical judgment and circumstances. Standards, on the other hand, are really meant primarily for the organization of care and are intended to have a higher level of obligation to help drive either practice or policy or even legislative efforts. So that's really the distinction. And what are the standard statements that are made by ASCO in this publication? The publication really is about safe handling of hazardous drugs. This all came about is because recently there have been a number of national guidelines or standards that have been offered by other organizations, but not specifically oncology or certainly ASCO or the ASCO organization. We felt a need to address the standards that have been put out on the basis of the evidence, so that best practices can be offered. Initially, we did collaborate with other societies, such as the Oncology Nursing Society and the Hematology Oncology Pharmacy Association. That was really the impetus behind making sure that we are, in a sense, congruent with standards that are already being published and discussed, but also to also place in our interpretation of these standards so that they're based on the best evidence that's available. And what qualifying statements are there to note about these standards? Well, I think the best way to look at these standards is there has been recently published or offered what's been called the UST 800 standards, which really incorporate other previous standards by the Pharmacy Association as well as OSHA, the Occupational Safety and Health Association, as well as NIOSH, the American Society of Hospital Pharmacists, Oncology Nursing, etc. So there's a lot of standards that have been offered. And in fact, the ASCO review of this really in a sense agrees with many of the standards that have already been published and offered-- types of exposures, the responsibilities of personnel handling the drugs, the personal protective equipment, how we communicate the hazardous drugs, the training of compounding personnel, how the drugs are dispensed and even transported. So there's lots of things that we really do agree with. I think it's also important to understand that the objectives of this is really to protect personnel and the environment to make sure the standards apply to all personnel who compound hazardous drugs and preparations, all places where hazardous drugs are prepared and stored, transported and administered. So that's really a key part of this. These are a comprehensive program really to prevent worker environmental exposure and to provide the most practical safety environment for all involved. So finally, why are these standards so important? And how will they affect practice? Well, they effect practice in many ways. I mean, the key thing is making sure that our employees, meaning the nurses, pharmacy, the technicians, really everyone involved that they're not unduly exposed to these hazardous drugs. And so that's really the key thing that we're all trying to achieve by this. Now, what really makes the sort of ASCO standards somewhat different or the things that we came into a contention with has to do with the differences that ASCO has come up with in contrast to some of the other standards. And these have to do with really four main areas within these standards. They have to do with medical surveillance, external ventilation, closed system transfer devices, and also proper assignment of our personnel while they may have either trying to conceive or pregnant or nursing. So those areas that in our review, the ASCO review, have come under some question. As an example, medical surveillance, there in some of the standards offered-- not ASCO's-- that there's a number of medical surveillance procedures that have been elucidated, that really we find, number one, have really not any proven value for our employees and generate a lot of confusion in terms of how this process is supposed to be done. Obviously, if one of our employees has some undue exposure, such as a spill of chemotherapy or even just have flat out a concern, then obviously those things will be clearly investigated. But to have general medical surveillance of all employees, really we did not feel was of great value. But also further, we really feel that this is an area where more research needs to be done to better elucidate really what should this process look like and what value are we providing to our employees. Another aspect of this is the use of what are called closed system transfer devices. Currently, there are a number of these devices available that there is interestingly no standard way that these devices have been evaluated. And so it's hard to recommend one device over another, because there is no standards for which they're really being compared. And there certainly have been no studies looking at really any form of health outcome that really help us to direct this to how best to use these devices. And so really, a lot of these objections are more around let's do things in an evidence-based way so we can better know how to best direct our practices. Another area of concern in terms of ASCO standards have been the implementation of external ventilation in either containment secondary engineering controls or other situations. And the challenges is that HEPA filters are probably appropriate for collecting solid or aerosolized particles, but don't capture vaporized drugs. But there's little data available on the ability of hazardous drugs to vaporize within the workplace environment and what those hazards really are. And so again, it's is a call for more research to have an optimal environment for preparing these drugs and without having to place undue burdens in terms of external ventilation. Another area is options for alternative duties for workers who are actively trying to conceive or are pregnant or breastfeeding. And these we recognize can be special burdens to small practices looking to implement alternative duty programs. There is a lot of controversy regarding the potential level of risk that really these workers really have. And basically our stance has been that we should have a policy that identifies alternative work options for workers who are trying to conceive, are pregnant or are breastfeeding, and that this information needs to be conveyed to these employees at the time of their hire so they understand what their risks are and what their options are within the workplace. Again, trying to make sure everyone is well informed and aware of what the work environment they're in and as their life circumstances change what they can do to change with this. I think the key is that we all feel that this is an area that we should have continued research on. And our standard, certainly ASCO's standards will continue to evolve as more and more research and evidence becomes available. Thank you so much for taking the time to explain these standards to us today, Dr. Celano. You're welcome. And thank you to all of our listeners for tuning into the ASCO Guidelines podcast series. If you've enjoyed what you've heard today, please rate and review the podcast and refer the show to a colleague
Pharmacy Future Leaders co-Host Joanne Pauyo interviews Michael A. Jackson, CEO of the Florida Pharmacy Association. The Florida Pharmacy Association believes that we must be "United to Advance Healthcare and Pharmacy Practice" Joanne and Michael discuss the issues facing today's practicing pharmacist within the state of Florida and the associaitons mission to help pharmacy professionals succeed to provide better patient care. Contact: Florida Pharmacy Association 610 North Adams Street Tallahassee, Florida 32301 Ph: (850) 222-2400 Email: fpa@pharmview.com See omnystudio.com/listener for privacy information.
Pharmacy Future Leaders co-Host Joanne Pauyo interviews Michael A. Jackson, CEO of the Florida Pharmacy Association. The Florida Pharmacy Association believes that we must be "United to Advance Healthcare and Pharmacy Practice" Joanne and Michael discuss the issues facing today's practicing pharmacist within the state of Florida and the associaitons mission to help pharmacy professionals succeed to provide better patient care. Contact: Florida Pharmacy Association 610 North Adams Street Tallahassee, Florida 32301 Ph: (850) 222-2400 Email: fpa@pharmview.com See omnystudio.com/listener for privacy information.
Pharmacy Future Leaders co-Host Joanne Pauyo interviews Michael A. Jackson, CEO of the Florida Pharmacy Association. The Florida Pharmacy Association believes that we must be "United to Advance Healthcare and Pharmacy Practice" Joanne and Michael discuss the issues facing today's practicing pharmacist within the state of Florida and the associaitons mission to help pharmacy professionals succeed to provide better patient care. Contact: Florida Pharmacy Association 610 North Adams Street Tallahassee, Florida 32301 Ph: (850) 222-2400 Email: fpa@pharmview.com
This Episode of 'Pharming Your Career' is brought to you by Dr. Albert's new online course, 57 Cool Jobs for Pharmacists. Get it at: pharmllc.teachable.com, and includes time one on one with Erin: https://pharmllc.teachable.com/p/57-cool-jobs-for-pharmacists. Kate's bio: Kate Gainer, PharmD serves as the Executive Vice President and CEO for Iowa Pharmacy Association (IPA), and has been in this role since 2012. The IPA serves as the sole organization representing the profession of pharmacy in Iowa and pharmacists in all practice settings. IPA's mission is to promote safe and effective medication use, improve the health of patients, and advance the profession of pharmacy. Gainer oversees strategic planning for IPA and its subsidiaries, as well as business development, professional affairs, and government relations. She has worked for the Iowa Pharmacy Association for over ten years, previously as the Vice President of Professional Affairs. She received her Doctor of Pharmacy degree from the University of Wisconsin – Madison and was named Young Alumnus of the Year in 2016. She completed a pharmacy practice residency with an emphasis in community care through Drake University and Medicap Pharmacy. In addition to serving as the Executive Vice President of the Iowa Pharmacy association, Kate is active in other pharmacy organizations on the national level including the National Alliance for State Pharmacy Associations, APhA, ASHP, NCPA and PACE. Kate was named to Des Moines' “40 under 40” in 2014 and has participated in and co-chaired Leadership Iowa. Her husband, Bob, is an attorney in Des Moines. They have 4 children who keep them on their toes and perpetually sleep-deprived. (Ray – 6, Genevieve – 5, Telly and Tessa – 2). NASPA - https://naspa.us ASAE - https://www.asaecenter.org CAE Certification for Association Executives - https://www.asaecenter.org/programs/cae-certification For Students/Residents/Fellows - check out associations for rotations/residencies/fellowships - IA, TN, MI, AR, MO, ASHP, APhA, NCPA, NACDS, PQA Iowa Pharmacy Association - https://www.iarx.org June Meeting in June - https://www.iarx.org/ipaannualmtg IPA on Facebook - https://www.facebook.com/iowapharmacy on Instagram - https://www.instagram.com/iowapharmacyipa/ LinkedIn Group - https://www.linkedin.com/groups/2725699/profile on Twitter - https://twitter.com/IowaPharmacyIPA @IowaPharmacyIPA Dr. Gainer's profile on LinkedIn - https://www.linkedin.com/in/kate-gainer-bb4b646/ @IPA_kate on Twitter See omnystudio.com/listener for privacy information.
This Episode of 'Pharming Your Career' is brought to you by Dr. Albert's new online course, 57 Cool Jobs for Pharmacists. Get it at: pharmllc.teachable.com, and includes time one on one with Erin: https://pharmllc.teachable.com/p/57-cool-jobs-for-pharmacists. Kate's bio: Kate Gainer, PharmD serves as the Executive Vice President and CEO for Iowa Pharmacy Association (IPA), and has been in this role since 2012. The IPA serves as the sole organization representing the profession of pharmacy in Iowa and
Time to Talk CINV
South Carolina Pharmacy Association Ron Lanton Interviews Craig Burridge with the South Carolina Pharmacy Assocation. Craig Burridge, MS, CAE Mr. Burridge joined SCPhA in May 2013. He was previously the Executive Director of the Pharmacists Society of the State of New York. He has a Bachelor of Science in Political Science from the State University of New York at Buffalo. Craig attended the London School of Economics and Political Science on scholarship and has his Master of Science in Public Service from Russell Sage College. He earned his Certified Association Executive (CAE) designation in from the American Society of Association Executives. Craig served as President of the National Alliance of State Pharmacy Associations from 2007-08. In addition to serving on many volunteer boards, Mr. Burridge has served on the NYS Cancer Consortium Steering Committee, City of Cohoes Housing Authority, the Cohoes Music Hall Board of Directors and on the Albany County Youth Bureau. SCPhA TodayIn the more recent past, the Association has played a significant part in the role of continuing education requirements for pharmacists. As the science of pharmacy became more sophisticated, the Association saw the importance of insuring that pharmacists stay abreast of the rapidly changing information. SCPhA is an Accreditation Council for Pharmacy Education (ACPE) approved provider for continuing education. The Association constantly strives to offer readily available and quality education services to South Carolina pharmacists. SCPhA's legislative influence has gained strength in recent years. Through tremendous work of SCPhA's Legislative Network, H3631, "Rx Freedom of Access" was passed by the SC General Assembly and signed into state law in May 1994. The Association led the effort for a complete revision of the Pharmacy Practice Act, which was signed into law in June of 1998. SCPhA has grown from its original 50 male members and no staff to more than 2,000 male and female pharmacy professionals and a full-time staff of 7 professionals. These members and staff continue to work toward positive changes that sustain the profession of pharmacy. See omnystudio.com/listener for privacy information.
South Carolina Pharmacy Association Ron Lanton Interviews Craig Burridge with the South Carolina Pharmacy Assocation. Craig Burridge, MS, CAE Mr. Burridge joined SCPhA in May 2013. He was previously the Executive Director of the Pharmacists Society of the State of New York. He has a Bachelor of Science in Pol